NYSE:CIHealthcare
Cigna FTC Settlement Reshapes Express Scripts Model And Investor Outlook
Cigna Group (NYSE: CI) has reached a landmark settlement with the Federal Trade Commission affecting its Express Scripts pharmacy benefit operations.
The agreement requires the company to eliminate spread pricing, increase fee and rebate transparency, relocate group purchasing activities to the U.S., and adopt new cost models for independent pharmacies.
This settlement introduces binding changes to how Cigna structures and discloses elements of its pharmacy benefit management...